Clinical Trials Directory

Trials / Unknown

UnknownNCT00916695

Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques

Everolimus-Eluting Stent in the Treatment of Bifurcation Lesions: Comparison of Main Vessel Stent to Main Vessel and Side Branch Stent

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
332 (estimated)
Sponsor
Spanish Society of Cardiology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of the treatment of true bifurcation lesions with the XIENCE V stent using the simple strategy (stent in main vessel and provisional T-stenting in the side branch) compared to the complex strategy (stent in main vessel and T-stenting in the side branch).

Conditions

Interventions

TypeNameDescription
DEVICEXience V Everolimus Eluting Coronary Stent System. Abbott Laboratories. Abbott Park, Illinois, U.S.A.Complex PCI strategy for bifurcation: After optional pre-dilation of one or both vessels (main and side branch), and subsequent implanting of the stent in the main vessel, the side branch is approached by implanting a new stent as T technique. Simple PCI strategy for bifurcation: After optional pre-dilation of one or both vessels (main and side branch), a stent is deployed at main vessel. Side branch is approached by using provisional T stenting technique.

Timeline

Start date
2009-06-01
Primary completion
2011-02-01
Completion
2011-02-01
First posted
2009-06-09
Last updated
2009-07-23

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT00916695. Inclusion in this directory is not an endorsement.